{"transactions":[{"id":4634058,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":214,"kind":"person","name":"D'Silva Andrew J.","position":1,"cik":"0002083717","reported_name":"D'Silva Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-10-02T18:00:13.000Z","date":"2026-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":414,"price":8.39,"value":3473.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":99246,"source":{"system":"sec-edgar","filing":"0001628280-26-064386","document":"wk-form4_1790949611.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2083717/000162828026064386/wk-form4_1790949611.xml","form_type":"4"}},{"id":242,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":214,"kind":"person","name":"D'Silva Andrew J.","position":1,"cik":"0002083717","reported_name":"D'Silva Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-09-02T19:20:09.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1432,"price":7.86,"value":11255.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":99660,"source":{"system":"sec-edgar","filing":"0001628280-26-060059","document":"wk-form4_1788376806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2083717/000162828026060059/wk-form4_1788376806.xml","form_type":"4"}},{"id":677328,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-24T20:58:19.000Z","date":"2026-08-20","kind":"grant","planned":false,"acquired":true,"shares":79200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 20, 2027, which is the first anniversary of the grant date."}],"balance_after":262751,"source":{"system":"sec-edgar","filing":"0001628280-26-058673","document":"wk-form4_1787605097.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026058673/wk-form4_1787605097.xml","form_type":"4"}},{"id":677695,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":214,"kind":"person","name":"D'Silva Andrew J.","position":1,"cik":"0002083717","reported_name":"D'Silva Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-08-24T20:58:02.000Z","date":"2026-08-20","kind":"grant","planned":false,"acquired":true,"shares":57600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 20, 2027, which is the first anniversary of the grant date."}],"balance_after":101092,"source":{"system":"sec-edgar","filing":"0001628280-26-058672","document":"wk-form4_1787605080.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2083717/000162828026058672/wk-form4_1787605080.xml","form_type":"4"}},{"id":677327,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20329,"kind":"person","name":"Merrell Brendan W.","position":1,"cik":"0002090383","reported_name":"Merrell Brendan W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-08-24T20:57:26.000Z","date":"2026-08-20","kind":"grant","planned":false,"acquired":true,"shares":57600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 20, 2027, which is the first anniversary of the grant date."}],"balance_after":82787,"source":{"system":"sec-edgar","filing":"0001628280-26-058670","document":"wk-form4_1787605044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026058670/wk-form4_1787605044.xml","form_type":"4"}},{"id":677513,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2026-08-24T20:57:08.000Z","date":"2026-08-20","kind":"grant","planned":false,"acquired":true,"shares":57600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 20, 2027, which is the first anniversary of the grant date."}],"balance_after":148007,"source":{"system":"sec-edgar","filing":"0001628280-26-058669","document":"wk-form4_1787605026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828026058669/wk-form4_1787605026.xml","form_type":"4"}},{"id":677326,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20329,"kind":"person","name":"Merrell Brendan W.","position":1,"cik":"0002090383","reported_name":"Merrell Brendan W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-08-24T19:14:54.000Z","date":"2026-08-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1020,"price":7.71,"value":7864.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":25187,"source":{"system":"sec-edgar","filing":"0001628280-26-058589","document":"wk-form4_1787598891.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026058589/wk-form4_1787598891.xml","form_type":"4"}},{"id":677325,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-24T19:14:15.000Z","date":"2026-08-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1737,"price":7.71,"value":13392.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":183551,"source":{"system":"sec-edgar","filing":"0001628280-26-058588","document":"wk-form4_1787598852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026058588/wk-form4_1787598852.xml","form_type":"4"}},{"id":677512,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2026-08-24T19:12:57.000Z","date":"2026-08-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1529,"price":7.71,"value":11788.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":90407,"source":{"system":"sec-edgar","filing":"0001628280-26-058586","document":"wk-form4_1787598774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828026058586/wk-form4_1787598774.xml","form_type":"4"}},{"id":677694,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":214,"kind":"person","name":"D'Silva Andrew J.","position":1,"cik":"0002083717","reported_name":"D'Silva Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-08-24T19:12:20.000Z","date":"2026-08-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1243,"price":7.71,"value":9583.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":43492,"source":{"system":"sec-edgar","filing":"0001628280-26-058584","document":"wk-form4_1787598737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2083717/000162828026058584/wk-form4_1787598737.xml","form_type":"4"}},{"id":677322,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20326,"kind":"person","name":"Stelmakh Edward","position":1,"cik":"0001887046","reported_name":"Stelmakh Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Finance & Strat Officer"}}],"security":"Common Stock","published_at":"2026-08-24T19:11:48.000Z","date":"2026-08-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1381,"price":7.71,"value":10647.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person."}],"balance_after":121791,"source":{"system":"sec-edgar","filing":"0001628280-26-058583","document":"wk-form4_1787598706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026058583/wk-form4_1787598706.xml","form_type":"4"}},{"id":743245,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39689,"kind":"person","name":"KLEMA CATHY","position":1,"cik":"0001181157","reported_name":"KLEMA CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T17:44:36.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":34517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":56137,"source":{"system":"sec-edgar","filing":"0001628280-26-042133","document":"wk-form4_1781113474.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181157/000162828026042133/wk-form4_1781113474.xml","form_type":"4"}},{"id":743037,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T17:39:38.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":34517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":433837,"source":{"system":"sec-edgar","filing":"0001628280-26-042132","document":"wk-form4_1781113175.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026042132/wk-form4_1781113175.xml","form_type":"4"}},{"id":743036,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39644,"kind":"person","name":"Presti Mariyamma Varghese","position":1,"cik":"0002131226","reported_name":"Presti Mariyamma Varghese","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T17:39:01.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":17258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":30318,"source":{"system":"sec-edgar","filing":"0001628280-26-042131","document":"wk-form4_1781113139.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026042131/wk-form4_1781113139.xml","form_type":"4"}},{"id":743035,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T17:38:23.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":34517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":78732,"source":{"system":"sec-edgar","filing":"0001628280-26-042130","document":"wk-form4_1781113100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026042130/wk-form4_1781113100.xml","form_type":"4"}},{"id":743034,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T17:37:49.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":34517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":107159,"source":{"system":"sec-edgar","filing":"0001628280-26-042129","document":"wk-form4_1781113066.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026042129/wk-form4_1781113066.xml","form_type":"4"}},{"id":743033,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":16110,"kind":"person","name":"WASSON GREGORY D","position":1,"cik":"0001188827","reported_name":"WASSON GREGORY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T17:37:18.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":34517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":91700,"source":{"system":"sec-edgar","filing":"0001628280-26-042128","document":"wk-form4_1781113035.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026042128/wk-form4_1781113035.xml","form_type":"4"}},{"id":743032,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39644,"kind":"person","name":"Presti Mariyamma Varghese","position":1,"cik":"0002131226","reported_name":"Presti Mariyamma Varghese","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T17:18:04.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":13060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the first anniversary of the date of the grant."}],"balance_after":13060,"source":{"system":"sec-edgar","filing":"0001628280-26-042124","document":"wk-form4_1781111881.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026042124/wk-form4_1781111881.xml","form_type":"4"}},{"id":774867,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":46417,"kind":"person","name":"Greco Theresa","position":1,"cik":"0001998771","reported_name":"Greco Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:44:34.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":879,"price":5.21,"value":4579.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":71075,"source":{"system":"sec-edgar","filing":"0001628280-26-036004","document":"wk-form4_1779137072.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026036004/wk-form4_1779137072.xml","form_type":"4"}},{"id":774866,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":46417,"kind":"person","name":"Greco Theresa","position":1,"cik":"0001998771","reported_name":"Greco Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:44:34.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":914,"price":5.21,"value":4761.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":71954,"source":{"system":"sec-edgar","filing":"0001628280-26-036004","document":"wk-form4_1779137072.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026036004/wk-form4_1779137072.xml","form_type":"4"}},{"id":774865,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:43:36.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5219,"price":5.21,"value":27190.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":185288,"source":{"system":"sec-edgar","filing":"0001628280-26-035998","document":"wk-form4_1779137014.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026035998/wk-form4_1779137014.xml","form_type":"4"}},{"id":905347,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-13T16:49:55.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 11, 2021, the reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 11, 2021, the reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001628280-26-007972","document":"wk-form4_1771001391.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828026007972/wk-form4_1771001391.xml","form_type":"4"}},{"id":905346,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2026-02-13T16:49:55.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1386,"price":9.23,"value":12792.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":91936,"source":{"system":"sec-edgar","filing":"0001628280-26-007972","document":"wk-form4_1771001391.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828026007972/wk-form4_1771001391.xml","form_type":"4"}},{"id":905345,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2026-02-13T16:49:55.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":93322,"source":{"system":"sec-edgar","filing":"0001628280-26-007972","document":"wk-form4_1771001391.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828026007972/wk-form4_1771001391.xml","form_type":"4"}},{"id":959538,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-23T22:43:26.000Z","date":"2025-12-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":3361,"price":12.74,"value":42819.14,"ownership":{"direct":true},"balance_after":190507,"source":{"system":"sec-edgar","filing":"0001628280-25-058799","document":"wk-form4a_1766529803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025058799/wk-form4a_1766529803.xml","form_type":"4/A","original_submission_date":"2025-12-23"}},{"id":959537,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":46417,"kind":"person","name":"Greco Theresa","position":1,"cik":"0001998771","reported_name":"Greco Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-23T21:55:22.000Z","date":"2025-12-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":1420,"price":12.74,"value":18090.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":72868,"source":{"system":"sec-edgar","filing":"0001628280-25-058770","document":"wk-form4_1766526917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025058770/wk-form4_1766526917.xml","form_type":"4"}},{"id":959536,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-23T21:54:50.000Z","date":"2025-12-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":3361,"price":12.74,"value":42819.14,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares sold pursuant to a plan of disposition adopted on March 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":190507,"source":{"system":"sec-edgar","filing":"0001628280-25-058768","document":"wk-form4_1766526886.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025058768/wk-form4_1766526886.xml","form_type":"4"}},{"id":959734,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2025-12-23T21:53:55.000Z","date":"2025-12-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":4051,"price":12.74,"value":51609.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":89322,"source":{"system":"sec-edgar","filing":"0001628280-25-058763","document":"wk-form4_1766526832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025058763/wk-form4_1766526832.xml","form_type":"4"}},{"id":959535,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20326,"kind":"person","name":"Stelmakh Edward","position":1,"cik":"0001887046","reported_name":"Stelmakh Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Finance & Strat Officer"}}],"security":"Common Stock","published_at":"2025-12-23T21:52:31.000Z","date":"2025-12-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":3658,"price":12.74,"value":46602.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":123172,"source":{"system":"sec-edgar","filing":"0001628280-25-058758","document":"wk-form4_1766526748.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025058758/wk-form4_1766526748.xml","form_type":"4"}},{"id":959534,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20326,"kind":"person","name":"Stelmakh Edward","position":1,"cik":"0001887046","reported_name":"Stelmakh Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Finance & Strat Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-23T19:23:07.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":false,"shares":5237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date."}],"balance_after":5237,"derivative":{"expiration_date":"2026-12-19","underlying":"Common Stock","underlying_shares":5237},"source":{"system":"sec-edgar","filing":"0001628280-25-058715","document":"wk-form4a_1766517784.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025058715/wk-form4a_1766517784.xml","form_type":"4/A","original_submission_date":"2025-12-22"}},{"id":959533,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20326,"kind":"person","name":"Stelmakh Edward","position":1,"cik":"0001887046","reported_name":"Stelmakh Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Finance & Strat Officer"}}],"security":"Common Stock","published_at":"2025-12-23T19:23:07.000Z","date":"2025-12-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1388,"price":13.51,"value":18751.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This Form 4/A is filed to correct the transaction code in Table I. The disposition of 1,388 shares previously reported as Transaction Code S should have been reported as Transaction Code F to reflect shares withheld by the issuer to satisfy tax withholding obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":126830,"source":{"system":"sec-edgar","filing":"0001628280-25-058715","document":"wk-form4a_1766517784.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025058715/wk-form4a_1766517784.xml","form_type":"4/A","original_submission_date":"2025-12-22"}},{"id":959532,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20326,"kind":"person","name":"Stelmakh Edward","position":1,"cik":"0001887046","reported_name":"Stelmakh Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Finance & Strat Officer"}}],"security":"Common Stock","published_at":"2025-12-23T19:23:07.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":true,"shares":5237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":128218,"source":{"system":"sec-edgar","filing":"0001628280-25-058715","document":"wk-form4a_1766517784.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025058715/wk-form4a_1766517784.xml","form_type":"4/A","original_submission_date":"2025-12-22"}},{"id":959816,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":70896,"kind":"person","name":"Besch Doug","position":1,"cik":"0001947731","reported_name":"Besch Doug","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product & Tech Officer"}}],"security":"Common Stock","published_at":"2025-12-23T16:53:15.000Z","date":"2025-12-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":4079,"price":12.74,"value":51966.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":66876,"source":{"system":"sec-edgar","filing":"0001628280-25-058761","document":"wk-form4_1766526792.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947731/000162828025058761/wk-form4_1766526792.xml","form_type":"4"}},{"id":960851,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20326,"kind":"person","name":"Stelmakh Edward","position":1,"cik":"0001887046","reported_name":"Stelmakh Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Finance & Strat Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-22T15:10:47.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":false,"shares":5237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date."}],"balance_after":5237,"derivative":{"expiration_date":"2026-12-19","underlying":"Common Stock","underlying_shares":5237},"source":{"system":"sec-edgar","filing":"0001628280-25-058413","document":"wk-form4_1766416244.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025058413/wk-form4_1766416244.xml","form_type":"4"}},{"id":960850,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20326,"kind":"person","name":"Stelmakh Edward","position":1,"cik":"0001887046","reported_name":"Stelmakh Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Finance & Strat Officer"}}],"security":"Common Stock","published_at":"2025-12-22T15:10:47.000Z","date":"2025-12-19","kind":"sale","planned":false,"acquired":false,"shares":1388,"price":13.51,"value":18751.88,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":126830,"source":{"system":"sec-edgar","filing":"0001628280-25-058413","document":"wk-form4_1766416244.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025058413/wk-form4_1766416244.xml","form_type":"4"}},{"id":960849,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20326,"kind":"person","name":"Stelmakh Edward","position":1,"cik":"0001887046","reported_name":"Stelmakh Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Finance & Strat Officer"}}],"security":"Common Stock","published_at":"2025-12-22T15:10:47.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":true,"shares":5237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":128218,"source":{"system":"sec-edgar","filing":"0001628280-25-058413","document":"wk-form4_1766416244.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025058413/wk-form4_1766416244.xml","form_type":"4"}},{"id":960848,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-22T15:10:09.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":false,"shares":6546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date."}],"balance_after":6547,"derivative":{"expiration_date":"2026-12-19","underlying":"Common Stock","underlying_shares":6546},"source":{"system":"sec-edgar","filing":"0001628280-25-058412","document":"wk-form4_1766416206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025058412/wk-form4_1766416206.xml","form_type":"4"}},{"id":960847,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-22T15:10:09.000Z","date":"2025-12-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1594,"price":13.51,"value":21534.94,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":193868,"source":{"system":"sec-edgar","filing":"0001628280-25-058412","document":"wk-form4_1766416206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025058412/wk-form4_1766416206.xml","form_type":"4"}},{"id":960846,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-22T15:10:09.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":true,"shares":6546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":195462,"source":{"system":"sec-edgar","filing":"0001628280-25-058412","document":"wk-form4_1766416206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025058412/wk-form4_1766416206.xml","form_type":"4"}},{"id":961090,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-22T15:09:28.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":false,"shares":3928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date."}],"balance_after":3928,"derivative":{"exercise_date":"2024-12-19","expiration_date":"2026-12-19","underlying":"Common Stock","underlying_shares":3928},"source":{"system":"sec-edgar","filing":"0001628280-25-058411","document":"wk-form4_1766416165.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025058411/wk-form4_1766416165.xml","form_type":"4"}},{"id":961089,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2025-12-22T15:09:28.000Z","date":"2025-12-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1153,"price":13.51,"value":15577.03,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":93373,"source":{"system":"sec-edgar","filing":"0001628280-25-058411","document":"wk-form4_1766416165.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025058411/wk-form4_1766416165.xml","form_type":"4"}},{"id":961088,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2025-12-22T15:09:28.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":true,"shares":3928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":94526,"source":{"system":"sec-edgar","filing":"0001628280-25-058411","document":"wk-form4_1766416165.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025058411/wk-form4_1766416165.xml","form_type":"4"}},{"id":960845,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20329,"kind":"person","name":"Merrell Brendan W.","position":1,"cik":"0002090383","reported_name":"Merrell Brendan W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-12-22T15:08:45.000Z","date":"2025-12-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":289,"price":13.51,"value":3904.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":26207,"source":{"system":"sec-edgar","filing":"0001628280-25-058410","document":"wk-form4_1766416123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025058410/wk-form4_1766416123.xml","form_type":"4"}},{"id":961297,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":214,"kind":"person","name":"D'Silva Andrew J.","position":1,"cik":"0002083717","reported_name":"D'Silva Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-12-22T15:07:58.000Z","date":"2025-12-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":703,"price":13.51,"value":9497.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":44735,"source":{"system":"sec-edgar","filing":"0001628280-25-058409","document":"wk-form4_1766416075.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2083717/000162828025058409/wk-form4_1766416075.xml","form_type":"4"}},{"id":961164,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":70896,"kind":"person","name":"Besch Doug","position":1,"cik":"0001947731","reported_name":"Besch Doug","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product & Tech Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-22T10:07:15.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":false,"shares":1964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date."}],"balance_after":1964,"derivative":{"expiration_date":"2026-12-19","underlying":"Common Stock","underlying_shares":1964},"source":{"system":"sec-edgar","filing":"0001628280-25-058408","document":"wk-form4_1766416032.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1947731/000162828025058408/wk-form4_1766416032.xml","form_type":"4"}},{"id":961163,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":70896,"kind":"person","name":"Besch Doug","position":1,"cik":"0001947731","reported_name":"Besch Doug","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product & Tech Officer"}}],"security":"Common Stock","published_at":"2025-12-22T10:07:15.000Z","date":"2025-12-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":581,"price":13.51,"value":7849.31,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":70955,"source":{"system":"sec-edgar","filing":"0001628280-25-058408","document":"wk-form4_1766416032.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1947731/000162828025058408/wk-form4_1766416032.xml","form_type":"4"}},{"id":961162,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":70896,"kind":"person","name":"Besch Doug","position":1,"cik":"0001947731","reported_name":"Besch Doug","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product & Tech Officer"}}],"security":"Common Stock","published_at":"2025-12-22T10:07:15.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":true,"shares":1964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":71536,"source":{"system":"sec-edgar","filing":"0001628280-25-058408","document":"wk-form4_1766416032.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947731/000162828025058408/wk-form4_1766416032.xml","form_type":"4"}},{"id":969326,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20329,"kind":"person","name":"Merrell Brendan W.","position":1,"cik":"0002090383","reported_name":"Merrell Brendan W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-12-16T00:46:58.000Z","date":"2025-12-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":712,"price":14.03,"value":9989.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of\nsecurities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":26496,"source":{"system":"sec-edgar","filing":"0001628280-25-057201","document":"wk-form4_1765846015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025057201/wk-form4_1765846015.xml","form_type":"4"}},{"id":969806,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":214,"kind":"person","name":"D'Silva Andrew J.","position":1,"cik":"0002083717","reported_name":"D'Silva Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-12-16T00:43:10.000Z","date":"2025-12-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":868,"price":14.03,"value":12178.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations.  Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":45438,"source":{"system":"sec-edgar","filing":"0001628280-25-057199","document":"wk-form4_1765845787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2083717/000162828025057199/wk-form4_1765845787.xml","form_type":"4"}},{"id":1003588,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20329,"kind":"person","name":"Merrell Brendan W.","position":1,"cik":"0002090383","reported_name":"Merrell Brendan W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option","published_at":"2025-11-10T14:55:53.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":23437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date."}],"balance_after":46874,"derivative":{"exercise_price":16.14,"expiration_date":"2030-08-21","underlying":"Common Stock","underlying_shares":23437},"source":{"system":"sec-edgar","filing":"0001628280-25-050825","document":"wk-form4_1762786550.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025050825/wk-form4_1762786550.xml","form_type":"4"}},{"id":1003587,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20329,"kind":"person","name":"Merrell Brendan W.","position":1,"cik":"0002090383","reported_name":"Merrell Brendan W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-11-10T14:55:53.000Z","date":"2025-10-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":483,"price":18.75,"value":9056.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":27208,"source":{"system":"sec-edgar","filing":"0001628280-25-050825","document":"wk-form4_1762786550.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025050825/wk-form4_1762786550.xml","form_type":"4"}},{"id":1003586,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20329,"kind":"person","name":"Merrell Brendan W.","position":1,"cik":"0002090383","reported_name":"Merrell Brendan W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-11-10T14:55:53.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on\nAugust 21, 2026, which is the first anniversary of the grant date."}],"balance_after":27691,"source":{"system":"sec-edgar","filing":"0001628280-25-050825","document":"wk-form4_1762786550.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025050825/wk-form4_1762786550.xml","form_type":"4"}},{"id":1005033,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":214,"kind":"person","name":"D'Silva Andrew J.","position":1,"cik":"0002083717","reported_name":"D'Silva Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-11-07T22:51:07.000Z","date":"2025-10-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":794,"price":18.75,"value":14887.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":46306,"source":{"system":"sec-edgar","filing":"0001628280-25-050744","document":"wk-form4_1762555864.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2083717/000162828025050744/wk-form4_1762555864.xml","form_type":"4"}},{"id":1005032,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":214,"kind":"person","name":"D'Silva Andrew J.","position":1,"cik":"0002083717","reported_name":"D'Silva Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-11-07T22:51:07.000Z","date":"2025-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":414,"price":18.98,"value":7857.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":47100,"source":{"system":"sec-edgar","filing":"0001628280-25-050744","document":"wk-form4_1762555864.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2083717/000162828025050744/wk-form4_1762555864.xml","form_type":"4"}},{"id":1009534,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":46417,"kind":"person","name":"Greco Theresa","position":1,"cik":"0001998771","reported_name":"Greco Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-04T01:12:54.000Z","date":"2025-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1693,"price":20.49,"value":34689.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":74288,"source":{"system":"sec-edgar","filing":"0001628280-25-048472","document":"wk-form4_1762218771.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025048472/wk-form4_1762218771.xml","form_type":"4"}},{"id":1022267,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-07T22:46:15.000Z","date":"2025-10-03","kind":"exercise","planned":false,"acquired":false,"shares":6649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6649},"source":{"system":"sec-edgar","filing":"0001628280-25-044549","document":"wk-form4_1759877172.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025044549/wk-form4_1759877172.xml","form_type":"4"}},{"id":1022266,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2025-10-07T22:46:15.000Z","date":"2025-10-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1952,"price":18.75,"value":36600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":90598,"source":{"system":"sec-edgar","filing":"0001628280-25-044549","document":"wk-form4_1759877172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025044549/wk-form4_1759877172.xml","form_type":"4"}},{"id":1022265,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2025-10-07T22:46:15.000Z","date":"2025-10-03","kind":"exercise","planned":false,"acquired":true,"shares":6649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":92550,"source":{"system":"sec-edgar","filing":"0001628280-25-044549","document":"wk-form4_1759877172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025044549/wk-form4_1759877172.xml","form_type":"4"}},{"id":1022135,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-07T22:26:20.000Z","date":"2025-10-03","kind":"exercise","planned":false,"acquired":false,"shares":6649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6649},"source":{"system":"sec-edgar","filing":"0001628280-25-044543","document":"wk-form4_1759875977.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025044543/wk-form4_1759875977.xml","form_type":"4"}},{"id":1022134,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-07T22:26:20.000Z","date":"2025-10-03","kind":"sale","planned":false,"acquired":false,"shares":1620,"price":18.75,"value":30375.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":188916,"source":{"system":"sec-edgar","filing":"0001628280-25-044543","document":"wk-form4_1759875977.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025044543/wk-form4_1759875977.xml","form_type":"4"}},{"id":1022133,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-07T22:26:20.000Z","date":"2025-10-03","kind":"exercise","planned":false,"acquired":true,"shares":6649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":190536,"source":{"system":"sec-edgar","filing":"0001628280-25-044543","document":"wk-form4_1759875977.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025044543/wk-form4_1759875977.xml","form_type":"4"}},{"id":1022131,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20326,"kind":"person","name":"Stelmakh Edward","position":1,"cik":"0001887046","reported_name":"Stelmakh Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Finance & Strat Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-07T22:25:59.000Z","date":"2025-10-03","kind":"exercise","planned":false,"acquired":false,"shares":16623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16623},"source":{"system":"sec-edgar","filing":"0001628280-25-044542","document":"wk-form4_1759875956.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025044542/wk-form4_1759875956.xml","form_type":"4"}},{"id":1022130,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20326,"kind":"person","name":"Stelmakh Edward","position":1,"cik":"0001887046","reported_name":"Stelmakh Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Finance & Strat Officer"}}],"security":"Common Stock","published_at":"2025-10-07T22:25:59.000Z","date":"2025-10-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":4406,"price":18.75,"value":82612.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":122981,"source":{"system":"sec-edgar","filing":"0001628280-25-044542","document":"wk-form4_1759875956.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025044542/wk-form4_1759875956.xml","form_type":"4"}},{"id":1022129,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20326,"kind":"person","name":"Stelmakh Edward","position":1,"cik":"0001887046","reported_name":"Stelmakh Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Finance & Strat Officer"}}],"security":"Common Stock","published_at":"2025-10-07T22:25:59.000Z","date":"2025-10-03","kind":"exercise","planned":false,"acquired":true,"shares":16623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":127387,"source":{"system":"sec-edgar","filing":"0001628280-25-044542","document":"wk-form4_1759875956.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025044542/wk-form4_1759875956.xml","form_type":"4"}},{"id":1022331,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":70896,"kind":"person","name":"Besch Doug","position":1,"cik":"0001947731","reported_name":"Besch Doug","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product & Tech Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-07T17:52:24.000Z","date":"2025-10-03","kind":"exercise","planned":false,"acquired":false,"shares":3325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3325},"source":{"system":"sec-edgar","filing":"0001628280-25-044540","document":"wk-form4_1759873941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1947731/000162828025044540/wk-form4_1759873941.xml","form_type":"4"}},{"id":1022330,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":70896,"kind":"person","name":"Besch Doug","position":1,"cik":"0001947731","reported_name":"Besch Doug","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product & Tech Officer"}}],"security":"Common Stock","published_at":"2025-10-07T17:52:24.000Z","date":"2025-10-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":983,"price":18.75,"value":18431.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":69572,"source":{"system":"sec-edgar","filing":"0001628280-25-044540","document":"wk-form4_1759873941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1947731/000162828025044540/wk-form4_1759873941.xml","form_type":"4"}},{"id":1022329,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":70896,"kind":"person","name":"Besch Doug","position":1,"cik":"0001947731","reported_name":"Besch Doug","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product & Tech Officer"}}],"security":"Common Stock","published_at":"2025-10-07T17:52:24.000Z","date":"2025-10-03","kind":"exercise","planned":false,"acquired":true,"shares":3325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":70555,"source":{"system":"sec-edgar","filing":"0001628280-25-044540","document":"wk-form4_1759873941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947731/000162828025044540/wk-form4_1759873941.xml","form_type":"4"}},{"id":1022382,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":214,"kind":"person","name":"D'Silva Andrew J.","position":1,"cik":"0002083717","reported_name":"D'Silva Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option","published_at":"2025-10-07T15:26:07.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":23437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date."}],"balance_after":23437,"derivative":{"exercise_price":16.14,"expiration_date":"2030-08-21","underlying":"Common Stock","underlying_shares":23437},"source":{"system":"sec-edgar","filing":"0001628280-25-044426","document":"wk-form4_1759850764.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2083717/000162828025044426/wk-form4_1759850764.xml","form_type":"4"}},{"id":1022381,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":214,"kind":"person","name":"D'Silva Andrew J.","position":1,"cik":"0002083717","reported_name":"D'Silva Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-10-07T15:26:07.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date."}],"balance_after":47514,"source":{"system":"sec-edgar","filing":"0001628280-25-044426","document":"wk-form4_1759850764.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2083717/000162828025044426/wk-form4_1759850764.xml","form_type":"4"}},{"id":1042738,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T17:55:07.000Z","date":"2025-08-28","kind":"sale","planned":false,"acquired":false,"shares":11120,"price":17.49,"value":194488.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.47 through $18.43. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, complete information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":44215,"source":{"system":"sec-edgar","filing":"0001296525-25-000002","document":"wk-form4_1757613304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000129652525000002/wk-form4_1757613304.xml","form_type":"4"}},{"id":1056756,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2025-08-25T20:32:47.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":35156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date."}],"balance_after":35156,"derivative":{"exercise_price":16.14,"exercise_date":"2026-08-21","expiration_date":"2030-08-21","underlying":"Common Stock","underlying_shares":35156},"source":{"system":"sec-edgar","filing":"0001628280-25-041119","document":"wk-form4_1756153962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025041119/wk-form4_1756153962.xml","form_type":"4"}},{"id":1056755,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-25T20:32:47.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date."}],"balance_after":183887,"source":{"system":"sec-edgar","filing":"0001628280-25-041119","document":"wk-form4_1756153962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025041119/wk-form4_1756153962.xml","form_type":"4"}},{"id":1056877,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Stock Option","published_at":"2025-08-25T20:29:19.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":35156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date."}],"balance_after":35156,"derivative":{"exercise_price":16.14,"exercise_date":"2026-08-21","expiration_date":"2030-08-21","underlying":"Common Stock","underlying_shares":35156},"source":{"system":"sec-edgar","filing":"0001628280-25-041117","document":"wk-form4_1756153755.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025041117/wk-form4_1756153755.xml","form_type":"4"}},{"id":1056876,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2025-08-25T20:29:19.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date."}],"balance_after":85901,"source":{"system":"sec-edgar","filing":"0001628280-25-041117","document":"wk-form4_1756153755.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025041117/wk-form4_1756153755.xml","form_type":"4"}},{"id":1056752,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20326,"kind":"person","name":"Stelmakh Edward","position":1,"cik":"0001887046","reported_name":"Stelmakh Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/COO"}}],"security":"Stock Option","published_at":"2025-08-25T19:21:06.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":35156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date."}],"balance_after":35156,"derivative":{"exercise_price":16.14,"exercise_date":"2026-08-21","expiration_date":"2030-08-21","underlying":"Common Stock","underlying_shares":35156},"source":{"system":"sec-edgar","filing":"0001628280-25-041110","document":"wk-form4_1756149661.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025041110/wk-form4_1756149661.xml","form_type":"4"}},{"id":1056751,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20326,"kind":"person","name":"Stelmakh Edward","position":1,"cik":"0001887046","reported_name":"Stelmakh Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/COO"}}],"security":"Common Stock","published_at":"2025-08-25T19:21:06.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date."}],"balance_after":110764,"source":{"system":"sec-edgar","filing":"0001628280-25-041110","document":"wk-form4_1756149661.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025041110/wk-form4_1756149661.xml","form_type":"4"}},{"id":1056754,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":46417,"kind":"person","name":"Greco Theresa","position":1,"cik":"0001998771","reported_name":"Greco Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2025-08-25T19:17:21.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":35156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date."}],"balance_after":35156,"derivative":{"exercise_price":16.14,"exercise_date":"2026-08-21","expiration_date":"2030-08-21","underlying":"Common Stock","underlying_shares":35156},"source":{"system":"sec-edgar","filing":"0001628280-25-041109","document":"wk-form4_1756149437.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025041109/wk-form4_1756149437.xml","form_type":"4"}},{"id":1056753,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":46417,"kind":"person","name":"Greco Theresa","position":1,"cik":"0001998771","reported_name":"Greco Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-25T19:17:21.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date."}],"balance_after":75981,"source":{"system":"sec-edgar","filing":"0001628280-25-041109","document":"wk-form4_1756149437.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025041109/wk-form4_1756149437.xml","form_type":"4"}},{"id":1056929,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":70896,"kind":"person","name":"Besch Doug","position":1,"cik":"0001947731","reported_name":"Besch Doug","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Prod & Tech Officer"}}],"security":"Stock Option","published_at":"2025-08-25T15:16:50.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":35156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date."}],"balance_after":35156,"derivative":{"exercise_price":16.14,"exercise_date":"2026-08-21","expiration_date":"2030-08-21","underlying":"Common Stock","underlying_shares":35156},"source":{"system":"sec-edgar","filing":"0001628280-25-041108","document":"wk-form4_1756149406.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1947731/000162828025041108/wk-form4_1756149406.xml","form_type":"4"}},{"id":1056928,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":70896,"kind":"person","name":"Besch Doug","position":1,"cik":"0001947731","reported_name":"Besch Doug","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Prod & Tech Officer"}}],"security":"Common Stock","published_at":"2025-08-25T15:16:50.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date."}],"balance_after":67230,"source":{"system":"sec-edgar","filing":"0001628280-25-041108","document":"wk-form4_1756149406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947731/000162828025041108/wk-form4_1756149406.xml","form_type":"4"}},{"id":1113575,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39689,"kind":"person","name":"KLEMA CATHY","position":1,"cik":"0001181157","reported_name":"KLEMA CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:36:16.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":9868,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":21620,"source":{"system":"sec-edgar","filing":"0001628280-25-031024","document":"wk-form4_1749760569.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181157/000162828025031024/wk-form4_1749760569.xml","form_type":"4"}},{"id":1113230,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:35:31.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":9868,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":399320,"source":{"system":"sec-edgar","filing":"0001628280-25-031022","document":"wk-form4_1749760525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025031022/wk-form4_1749760525.xml","form_type":"4"}},{"id":1113229,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39645,"kind":"person","name":"Spangler Patrick D","position":1,"cik":"0001296525","reported_name":"Spangler Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:34:57.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":9868,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":55335,"source":{"system":"sec-edgar","filing":"0001628280-25-031021","document":"wk-form4_1749760489.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025031021/wk-form4_1749760489.xml","form_type":"4"}},{"id":1113228,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:33:22.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":9868,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":72642,"source":{"system":"sec-edgar","filing":"0001628280-25-031019","document":"wk-form4_1749760393.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025031019/wk-form4_1749760393.xml","form_type":"4"}},{"id":1113223,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":16110,"kind":"person","name":"WASSON GREGORY D","position":1,"cik":"0001188827","reported_name":"WASSON GREGORY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:31:57.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":9868,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":57183,"source":{"system":"sec-edgar","filing":"0001628280-25-031015","document":"wk-form4_1749760310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025031015/wk-form4_1749760310.xml","form_type":"4"}},{"id":1142544,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":46417,"kind":"person","name":"Greco Theresa","position":1,"cik":"0001998771","reported_name":"Greco Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2025-05-19T20:04:14.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":12133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in three equal annual installments beginning May 15, 2026, the first anniversary of the grant date."}],"balance_after":12133,"derivative":{"exercise_price":10.65,"exercise_date":"2026-05-15","expiration_date":"2028-05-15","underlying":"Common Stock","underlying_shares":12133},"source":{"system":"sec-edgar","filing":"0001628280-25-026500","document":"wk-form4_1747685039.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025026500/wk-form4_1747685039.xml","form_type":"4"}},{"id":1142543,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":46417,"kind":"person","name":"Greco Theresa","position":1,"cik":"0001998771","reported_name":"Greco Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-19T20:04:14.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":7042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on May 15, 2026, which is the first anniversary of the date of the grant."}],"balance_after":60356,"source":{"system":"sec-edgar","filing":"0001628280-25-026500","document":"wk-form4_1747685039.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025026500/wk-form4_1747685039.xml","form_type":"4"}},{"id":1142542,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":46417,"kind":"person","name":"Greco Theresa","position":1,"cik":"0001998771","reported_name":"Greco Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-19T20:04:14.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":2441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest on May 15, 2026, which is the anniversary of the date of the grant."}],"balance_after":53314,"source":{"system":"sec-edgar","filing":"0001628280-25-026500","document":"wk-form4_1747685039.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025026500/wk-form4_1747685039.xml","form_type":"4"}},{"id":1142541,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2025-05-19T20:03:33.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":80884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in three equal annual installments beginning May 15, 2026, the first anniversary of the grant date."}],"balance_after":80884,"derivative":{"exercise_price":10.65,"exercise_date":"2026-05-15","expiration_date":"2029-05-15","underlying":"Common Stock","underlying_shares":80884},"source":{"system":"sec-edgar","filing":"0001628280-25-026499","document":"wk-form4_1747685005.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025026499/wk-form4_1747685005.xml","form_type":"4"}},{"id":1142540,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-19T20:03:33.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":46948,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on May 15, 2026, which is the first anniversary of the date of grant."}],"balance_after":168262,"source":{"system":"sec-edgar","filing":"0001628280-25-026499","document":"wk-form4_1747685005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025026499/wk-form4_1747685005.xml","form_type":"4"}},{"id":1196985,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-19T23:40:24.000Z","date":"2025-03-14","kind":"purchase","planned":false,"acquired":true,"shares":321408,"price":7.6033,"value":2443761.4464,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.18 through $7.80. The reporting person undertakes to provide to the Issuer., any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":389452,"source":{"system":"sec-edgar","filing":"0001628280-25-013918","document":"wk-form4_1742427618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025013918/wk-form4_1742427618.xml","form_type":"4"}},{"id":1227925,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-04T14:18:21.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":1928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vested in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1928},"source":{"system":"sec-edgar","filing":"0001628280-25-009631","document":"wk-form4_1741097894.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025009631/wk-form4_1741097894.xml","form_type":"4"}},{"id":1227924,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-04T14:18:21.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":572,"price":5.18,"value":2962.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":121314,"source":{"system":"sec-edgar","filing":"0001628280-25-009631","document":"wk-form4_1741097894.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025009631/wk-form4_1741097894.xml","form_type":"4"}},{"id":1227923,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-04T14:18:21.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":1928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."}],"balance_after":121886,"source":{"system":"sec-edgar","filing":"0001628280-25-009631","document":"wk-form4_1741097894.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025009631/wk-form4_1741097894.xml","form_type":"4"}},{"id":1229302,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer & CHRO"}}],"security":"Restricted Stock Units","published_at":"2025-03-04T14:16:52.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vested in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":771},"source":{"system":"sec-edgar","filing":"0001628280-25-009628","document":"wk-form4_1741097805.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025009628/wk-form4_1741097805.xml","form_type":"4"}},{"id":1229301,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer & CHRO"}}],"security":"Common Stock","published_at":"2025-03-04T14:16:52.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":268,"price":5.18,"value":1388.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":70276,"source":{"system":"sec-edgar","filing":"0001628280-25-009628","document":"wk-form4_1741097805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025009628/wk-form4_1741097805.xml","form_type":"4"}},{"id":1229300,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer & CHRO"}}],"security":"Common Stock","published_at":"2025-03-04T14:16:52.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."}],"balance_after":70544,"source":{"system":"sec-edgar","filing":"0001628280-25-009628","document":"wk-form4_1741097805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025009628/wk-form4_1741097805.xml","form_type":"4"}},{"id":1255620,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":35124,"kind":"person","name":"FEBBO WILLIAM J","position":1,"cik":"0001413987","reported_name":"FEBBO WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-02-20T18:40:27.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":401,"price":6.64,"value":2662.64,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":600852,"source":{"system":"sec-edgar","filing":"0001628280-25-006692","document":"wk-form4_1740076821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025006692/wk-form4_1740076821.xml","form_type":"4"}},{"id":1255618,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20326,"kind":"person","name":"Stelmakh Edward","position":1,"cik":"0001887046","reported_name":"Stelmakh Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/COO"}}],"security":"Common Stock","published_at":"2025-02-20T18:40:06.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2156,"price":6.64,"value":14315.84,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":95139,"source":{"system":"sec-edgar","filing":"0001628280-25-006691","document":"wk-form4_1740076800.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025006691/wk-form4_1740076800.xml","form_type":"4"}},{"id":1255619,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20328,"kind":"person","name":"Silvestro Stephen L","position":1,"cik":"0001773461","reported_name":"Silvestro Stephen L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-20T18:39:20.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2298,"price":6.64,"value":15258.72,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":119958,"source":{"system":"sec-edgar","filing":"0001628280-25-006689","document":"wk-form4_1740076754.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025006689/wk-form4_1740076754.xml","form_type":"4"}}],"next_cursor":"2025-02-20T18:39:20.000000Z,1255619"}